Trial NCT02624700

View at ClinicalTrials.gov 
Org. Study IDs: MCC-14-10790
Secondary IDs: HM20005967 NCI-2015-02190

Last trial update was posted on 2020-07-14

MeSH Interventions

Pemetrexed Sorafenib

MeSH Conditions

Breast Neoplasms Recurrence Triple Negative Breast Neoplasms

Other Conditions

Breast Cancer Metastatic Breast Cancer Recurrent Breast Cancer

Stopping Reasons

N/A

Limitations And Caveats

Incomplete objectives due to early termination of trial. Amendment to allow more heavily pretreated subjects to be enrolled required a change in starting doses (Arm B) for all subsequently enrolled subjects.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID